toxylact: a04ab57 chlorphenoxamine combinations

The first professional lActological database in the word

Chlorphenoxamine combinations (ATC A04AB57) are oral sedating antihistamine‑containing antiemetic products, used mainly for pruritus, motion sickness and antiparkinsonian indications, with relevant cautions in breastfeeding due to anticholinergic and sedative effects.medpedia.framar+6

ATC class overview

ATC A04AB57 belongs to the group of antiemetics and drugs against nausea (A04), within the subgroup of antihistamines used as vestibular suppressants and antiemetics (A04AB).^atcddd.fhi+2
Products in this class contain chlorphenoxamine in fixed combinations with other active substances (for example, sympathomimetics or other antiemetics), formulated for systemic, usually oral, use.drugs.ncats+3

Active substance and pharmacological profile

Chlorphenoxamine is a first‑generation ethanolamine‑class antihistamine, structurally related to diphenhydramine and acting as a histamine H1‑receptor antagonist.drugbank+4
It also has significant anticholinergic and sedative properties, which account for its antipruritic, antiemetic/anti‑motion‑sickness and antiparkinsonian uses.wikipedia+5

Therapeutic indications

In combinations classified as A04AB57, chlorphenoxamine is used to prevent and treat nausea and vomiting, particularly related to motion sickness or vestibular disorders.synapse.patsnap+3
Outside the antiemetic indication, it is employed as an antipruritic in allergic skin conditions and as an adjunct in Parkinson’s disease due to its central anticholinergic effect.build.openmodelica+4

A04AB57 chlorphenoxamine combinations are administered orally, with dose and regimen individualized according to age, indication, and the other components in the combination product.medpedia.framar+3
These medicines are prescription‑only (Rx), and initiation or dose adjustment should be performed by a physician familiar with the patient’s comorbidities and concomitant therapy.drugs.ncats+1

Adverse effects and toxicological considerations

Typical dose‑related adverse reactions include drowsiness, fatigue, dizziness and general weakness, reflecting central H1‑blockade and anticholinergic activity.drugbank+5
At higher exposures or in susceptible patients (elderly, those with CNS disease or polypharmacy), anticholinergic toxicity may manifest with confusion, agitation, blurred vision, tachycardia, urinary retention and, rarely, delirium or seizures.onlinelibrary.wiley+5

Contraindications and precautions

Use is contraindicated in individuals with known hypersensitivity to chlorphenoxamine or any component of the combination product.build.openmodelica+3
Caution is required in glaucoma, prostatic hypertrophy, urinary retention, cardiovascular disease, epilepsy, and in patients receiving other sedatives, anticholinergics or sympathomimetics, because of additive CNS and autonomic effects.synapse.patsnap+4

Lactation: exposure and potential risks

Like other sedating first‑generation antihistamines, chlorphenoxamine is expected to pass into breast milk in low amounts, but robust lactation pharmacokinetic data are lacking.nhs+3
Experience with related sedating H1‑antagonists (for example chlorphenamine) suggests that infant exposure is usually below a relative infant dose of 5%, yet sedation, poor feeding and, theoretically, reduced milk production may occur, particularly in neonates and young infants.theconversation+3

Lactation risk classification and clinical recommendations

On the basis of class data for sedating antihistamines and their known pharmacology, chlorphenoxamine‑containing combinations can be considered “compatible with breastfeeding with caution,” with preference for short‑term, lowest‑effective doses and close infant monitoring.healthdirect+3
Non‑sedating antihistamines (such as cetirizine or loratadine) are generally preferred for allergy in breastfeeding women, and non‑anticholinergic antiemetic strategies should be considered first line, reserving A04AB57 combinations for situations where benefits clearly outweigh potential risks to the infant and lactation.sps+4

Practical lactological guidance

If chlorphenoxamine combinations are used during breastfeeding, clinicians should monitor the breastfed child for excessive sleepiness, feeding difficulties, poor weight gain or unusual behavioral changes, and reassess therapy promptly if such signs appear.sps+4
Mothers should be advised to avoid prolonged, continuous use; schedule doses immediately after breastfeeding or before the infant’s longest sleep; and avoid co‑administration of other sedating drugs or decongestants that can further suppress prolactin and milk supply.theconversation+5

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.